表紙
市場調查報告書

血液檢驗 - 醫療設備開發平台評估:2019年

Hemostasis Tests - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 919481
出版日期 內容資訊 英文 301 Pages
訂單完成後即時交付
價格
Back to Top
血液檢驗 - 醫療設備開發平台評估:2019年 Hemostasis Tests - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月15日內容資訊: 英文 301 Pages
簡介

本報告提供全球血液檢驗市場相關調查,的主要開發中產品詳細內容 (產品說明,授權,合作詳細內容,其他開發活動) 、主要企業與其開發平台計劃,各種開發階段為基礎的開發中產品的檢討,主要的臨床實驗資料,市場區隔/產業上近幾年的開發趨勢等。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各市場區隔
  • 開發中產品:各領地
  • 開發中產品:各法規手續
  • 開發中產品:各預測的核准日

第4章 血液檢驗:開發中的開發中產品,各企業

  • 血液檢驗企業 - 開發中產品:各開發階段
  • 血液檢驗 - 開發中產品:各開發階段

第5章 血液檢驗企業、產品概要

第6章 血液檢驗:近幾年的發展

第7章 附錄

目錄
Product Code: GDME0838EPD

GlobalData's Medical Devices sector report, "Hemostasis Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Hemostasis Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hemostasis Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemostasis Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemostasis Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 7
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Hemostasis Tests Overview 15

3 Products under Development 17

  • 3.1 Hemostasis Tests - Pipeline Products by Stage of Development 17
  • 3.2 Hemostasis Tests - Pipeline Products by Segment 18
  • 3.3 Hemostasis Tests - Pipeline Products by Territory 19
  • 3.4 Hemostasis Tests - Pipeline Products by Regulatory Path 20
  • 3.5 Hemostasis Tests - Pipeline Products by Estimated Approval Date 21

4 Hemostasis Tests - Pipeline Products under Development by Companies 22

  • 4.1 Hemostasis Tests Companies - Pipeline Products by Stage of Development 22
  • 4.2 Hemostasis Tests - Pipeline Products by Stage of Development 24

5 Hemostasis Tests Companies and Product Overview 30

6 Hemostasis Tests- Recent Developments 163

7 Appendix 294

List of Tables

  • Table 1: Hemostasis Tests - Pipeline Products by Stage of Development 17
  • Table 2: Hemostasis Tests - Pipeline Products by Segment 18
  • Table 3: Hemostasis Tests - Pipeline Products by Territory 19
  • Table 4: Hemostasis Tests - Pipeline Products by Regulatory Path 20
  • Table 5: Hemostasis Tests - Pipeline Products by Estimated Approval Date 21
  • Table 6: Hemostasis Tests Companies - Pipeline Products by Stage of Development 22
  • Table 7: Hemostasis Tests - Pipeline Products by Stage of Development 24
  • Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 9: Afinion PT Test - Capillary Blood - Product Status 30
  • Table 10: Afinion PT Test - Capillary Blood - Product Description 30
  • Table 11: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 12: Coagulyzer 1 - Product Status 31
  • Table 13: Coagulyzer 1 - Product Description 32
  • Table 14: Coagulyzer 100 - Product Status 32
  • Table 15: Coagulyzer 100 - Product Description 33
  • Table 16: Coagulyzer 2 - Product Status 33
  • Table 17: Coagulyzer 2 - Product Description 34
  • Table 18: Coagulyzer 4 - Product Status 34
  • Table 19: Coagulyzer 4 - Product Description 35
  • Table 20: Fibrinogen Lyophilisat Coagulation Kit - Product Status 35
  • Table 21: Fibrinogen Lyophilisat Coagulation Kit - Product Description 36
  • Table 22: Atantares Corp Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 23: Platelet Function Assay - Product Status 37
  • Table 24: Platelet Function Assay - Product Description 37
  • Table 25: Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 26: AtomoRapid - Coagulation Monitoring - Product Status 38
  • Table 27: AtomoRapid - Coagulation Monitoring - Product Description 38
  • Table 28: BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 29: Portable Diagnostic System - Hemostasis - Product Status 39
  • Table 30: Portable Diagnostic System - Hemostasis - Product Description 39
  • Table 31: Braun Biosystems, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 32: Bio6 - Product Status 40
  • Table 33: Bio6 - Product Description 40
  • Table 34: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 35: Micropoc-CAT - Haemostasis Assay - Product Status 41
  • Table 36: Micropoc-CAT - Haemostasis Assay - Product Description 41
  • Table 37: Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 38: Multiple Blood Analytes Test - Product Status 42
  • Table 39: Multiple Blood Analytes Test - Product Description 42
  • Table 40: Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 41: Calibrated Automated Thrombogram - Thrombin Assay - Product Status 43
  • Table 42: Calibrated Automated Thrombogram - Thrombin Assay - Product Description 44
  • Table 43: STA Compact Max - NeoPTimal ISI - Product Status 44
  • Table 44: STA Compact Max - NeoPTimal ISI - Product Description 44
  • Table 45: STA Compact Max - Ristocetin Cofactor Assay - Product Status 45
  • Table 46: STA Compact Max - Ristocetin Cofactor Assay - Product Description 45
  • Table 47: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Status 45
  • Table 48: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Description 45
  • Table 49: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Status 46
  • Table 50: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Description 46
  • Table 51: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Status 46
  • Table 52: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Description 47
  • Table 53: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 47
  • Table 54: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 47
  • Table 55: STA-R Max - NeoPTimal ISI - Product Status 48

List of Figures

  • Figure 1: Hemostasis Tests - Pipeline Products by Stage of Development 17
  • Figure 2: Hemostasis Tests - Pipeline Products by Segment 18
  • Figure 3: Hemostasis Tests - Pipeline Products by Territory 19
  • Figure 4: Hemostasis Tests - Pipeline Products by Regulatory Path 20
  • Figure 5: Hemostasis Tests - Pipeline Products by Estimated Approval Date 21
Back to Top